Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.
Chaussin B, Sanchez L, Levesque S, Revy A, Tempier M, Montemagno C, Durivault J, Schmitt S, Boutault E, Besse S, Chautard E, Auriol M, Voissiere A, Kossaï M, Miot-Noirault E, Penault-Llorca F, Merlin C, Cachin F, Jouberton E.
Chaussin B, et al. Among authors: merlin c.
Sci Rep. 2026 Feb 16. doi: 10.1038/s41598-026-36724-7. Online ahead of print.
Sci Rep. 2026.
PMID: 41698968
Free article.
No abstract available.